Brief: FDA Says Assertio Specialty Pharmaceuticals Discontinues Manufacturing Of Otrexup, Injection
29/08/2025 14:51
Aug 29 (Reuters) - FDA: FDA: ASSERTIO SPECIALTY PHARMACEUTICALS DISCONTINUES MANUFACTURING OF OTREXUP, INJECTION- WEBSITE (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Assertio Holdings
See all newsBrief: Assertio Announces Completion Of Merger With Zydus Lifesciences And Fundamental Change
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE -Fervo, Sensata Technologies, Akamai
U.S. STOCKS ON THE MOVE-Chipmakers, Dynatrace, Alibaba